These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 11776354

  • 1. Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides.
    Nucci M, Landau M, Silveira F, Spector N, Pulcheri W.
    Infect Control Hosp Epidemiol; 2001 Oct; 22(10):651-3. PubMed ID: 11776354
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ceftazidime plus amikacin plus teicoplanin or vancomycin in the empirical antibiotic therapy in febrile neutropenic cancer patients.
    Nucci M, Biasoli I, Braggio S, Portugal R, Schaffel R, Maiolino A, Loureiro MM, Spector N, Pulcheri W.
    Oncol Rep; 1998 Oct; 5(5):1205-9. PubMed ID: 9683836
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.
    Glauser MP, Brennscheidt U, Cornely O, Grigg A, Figuera A, Keyserling C, Trostmann U, Welling L, Tack K.
    Clin Microbiol Infect; 2002 Jan; 8(1):14-25. PubMed ID: 11906496
    [Abstract] [Full Text] [Related]

  • 6. Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
    Montalar J, Segura A, Bosch C, Galan A, Juan O, Molins C, Giner V, Aparicio J.
    Med Oncol; 2002 Jan; 19(3):161-6. PubMed ID: 12482126
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
    Agaoglu L, Devecioglu O, Anak S, Karakas Z, Yalman N, Biner B, Eryilmaz E, Goksan B, Unuvar A, Agirbasli H, Can M, Bilgen H, Gedikoglu G.
    J Chemother; 2001 Jun; 13(3):281-7. PubMed ID: 11450887
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin].
    Brion JP, Bru JP, Michallet M, Corron B, Fauconnier J.
    Presse Med; 1988 Oct 26; 17(37):1964-7. PubMed ID: 2973597
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
    Fenu S, Raccah R, Santilli S, Micozzi A, Girmena C, Martino P, Avvisati G.
    Chemioterapia; 1988 Oct 26; 7(5):323-6. PubMed ID: 3066517
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.
    de la Cámara R, Figuera A, Sureda A, Hermida G, Verge G, Olalla I, Fernández Rañada JM, Domingo Albos A.
    Haematologica; 1997 Oct 26; 82(6):668-75. PubMed ID: 9580087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.